MacroGenics Correlations
| MGNX Stock | USD 1.69 0.03 1.74% |
The current 90-days correlation between MacroGenics and Ovid Therapeutics is 0.11 (i.e., Average diversification). The correlation of MacroGenics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
MacroGenics Correlation With Market
Poor diversification
The correlation between MacroGenics and DJI is 0.77 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MacroGenics and DJI in the same portfolio, assuming nothing else is changed.
MacroGenics | Build AI portfolio with MacroGenics Stock |
Moving together with MacroGenics Stock
| 0.7 | ENGN | enGene Holdings Common | PairCorr |
| 0.63 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.77 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.75 | MRKR | Marker Therapeutics | PairCorr |
| 0.72 | ANNX | Annexon | PairCorr |
| 0.71 | AVCR | Avricore Health | PairCorr |
| 0.66 | BOLT | Bolt Biotherapeutics | PairCorr |
| 0.69 | TNGX | Tango Therapeutics | PairCorr |
Moving against MacroGenics Stock
| 0.9 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.84 | ABP | Abpro Holdings | PairCorr |
| 0.81 | GNLX | Genelux Common | PairCorr |
| 0.8 | KURA | Kura Oncology | PairCorr |
| 0.77 | LYRA | Lyra Therapeutics | PairCorr |
| 0.74 | EDIT | Editas Medicine Earnings Call This Week | PairCorr |
| 0.69 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.6 | QSI | QuantumSi | PairCorr |
| 0.35 | EVGN | Evogene | PairCorr |
| 0.32 | LRMR | Larimar Therapeutics | PairCorr |
| 0.83 | MREO | Mereo BioPharma Group | PairCorr |
| 0.75 | ACXP | Acurx Pharmaceuticals LLC | PairCorr |
| 0.74 | PRQR | ProQR Therapeutics Earnings Call This Week | PairCorr |
| 0.65 | MBIO | Mustang Bio | PairCorr |
| 0.54 | AURA | Aura Biosciences | PairCorr |
| 0.4 | PROK | ProKidney Corp | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between MacroGenics Stock performing well and MacroGenics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MacroGenics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OVID | 4.27 | 0.46 | 0.07 | 2.14 | 4.85 | 9.70 | 36.13 | |||
| CNTX | 4.29 | 1.39 | 0.29 | (30.91) | 3.56 | 9.59 | 24.11 | |||
| CLNN | 5.04 | (1.16) | 0.00 | (0.46) | 0.00 | 9.44 | 38.74 | |||
| WHWK | 3.25 | 0.42 | 0.12 | 0.48 | 3.31 | 6.98 | 21.49 | |||
| STTK | 3.62 | 1.13 | 0.30 | 4.76 | 3.13 | 6.42 | 27.88 | |||
| CNTB | 4.71 | 1.07 | 0.17 | (0.58) | 4.38 | 11.93 | 38.27 | |||
| ORMP | 2.78 | 0.56 | 0.24 | 0.36 | 2.05 | 6.98 | 17.67 | |||
| ZNTL | 5.13 | 1.07 | 0.22 | 0.61 | 4.49 | 17.36 | 49.29 | |||
| COYA | 2.66 | (0.23) | 0.00 | (0.34) | 0.00 | 5.28 | 18.45 | |||
| IFRX | 4.63 | (0.55) | 0.00 | (0.14) | 0.00 | 7.84 | 43.11 |
MacroGenics Corporate Management
| Eric Risser | Sr. VP of Bus. Devel. and Portfolio Management | Profile | |
| Beth Smith | Controller VP | Profile | |
| Steve Harig | Senior Resources | Profile | |
| Christopher MD | VP Communications | Profile | |
| Harish Krishnaswamy | Senior Planning | Profile | |
| Ezio MD | Senior Officer | Profile |